Examining a Complex Heart Failure Case

Published: 25 February 2023

  • Views:

    Views Icon 4152
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Moderated by Prof Andrew JS Coats, this broadcast explores how a complex heart failure patient would be treated by a multidisciplinary team. In this unique discussion, we examine how the broader heart failure team can work together effectively and consider best practices for referral and initiation of foundational medical therapy.

 

This programme is supported by an unrestricted educational grant from AstraZeneca.

Learning Objectives

  • Identify individuals likely to have HFpEF from initial presentation
  • Refer suspected individuals for specialist assessment
  • Initiate GDMT for HF as soon as patients are stable
  • Initiate GDMT in HF regardless of EF and phenotype
  • Initiate shared decision-making on complex HF patients with other members of the multidisciplinary team including cardiologists, GPs, nephrologists and diabetologists

Target Audience

  • Cardiologists
  • Heart Failure Specialists
  • Primary Care Physicians
  • Nurses
  • Pharmacists
  • HCPs

More from this programme

Part 1

Re-cap and Summary

Prof Coats closes this programme by summarising key learning points from this complex case of HFpEF. 

Part 2

Opening our Case

Starting this series of videos, Prof Coats introduces the faculty, the programme agenda and presents our complex patient case study. 

Part 3

Approaching the Patient

Here the faculty discuss their initial approach to this patient from the perspective of their different backgrounds and how they can most effectively manage this patient as a team.   

Part 4

Diagnosing the Patient

The faculty discuss labelling the patient with a diagnosis, prioritising problems for management and ask who should start foundational therapy of SGLT-2 inhibitors. 

Part 5

Managing the Patient

The faculty review poll results from the audience on approach to management, discuss their approach to initiating GDMT and explore overcoming a dip in renal function following SGLT-2 inhibition.  

Part 6

Follow-up & Referral

The faculty now discuss the ongoing patient centred care required for this patient, continued investigation and holistic co-management.  

Part 7

Responding to a Changing Patient

Here the faculty discuss how they would continue to manage the patient with foundational therapy as their symptoms, disease severity and comorbidities change over time. Further audience questions are answered, exploring trail data, initiation and real world use of SGLT-2 inhibitors.    

About the episode

The faculty discuss labelling the patient with a diagnosis, prioritising problems for management and ask who should start foundational therapy of SGLT-2 inhibitors. 

Faculty Biographies

Andrew JS Coats

Andrew JS Coats

Professor of Cardiology and Scientific Director

Prof Coats is Editor-in-Chief of the Cardiac Failure Review journal. He has published over 20 patents, more than 750 full research papers and more than 120,000 career citations and has a personal H-index of 146. Andrew was elected to the Presidential Trio of the Heart Failure Association of the ESC in 2018 and will serve as its president from 2020-2022.

Prof Coats is the Immediate past-President of the Heart Failure Association and past-Professor of Cardiology at the University of Warwick, UK. He has also held posts as Head of Cardiology at Imperial College, London and Associate Medical Director and Director of Cardiology at the Royal Brompton and Harefield Hospitals, London. From 2012 to 2017 he was Director of the Monash-Warwick Alliance, and before that served as Deputy Vice-Chancellor and Dean of Medicine at the University of Sydney.

He is an…

View full profile
Silvio Inzucchi

Silvio Inzucchi

Professor of Medicine

Dr Silvio Inzucchi is a Professor of Medicine at the Yale University School of Medicine in New Haven, where he serves as Clinical Chief of the Section of Endocrinology, Medical Director of the Yale Diabetes Center, and Program Director of the Endocrinology & Metabolism Fellowship.

Dr Inzucchi has been an invited lecturer both nationally and internationally on many topics, most pertaining to clinical diabetes management. He has authored or co-authored more than 500 manuscripts, chapters, monographs, and abstracts, some published in the most prestigious medical journals, including the New England Journal of Medicine and JAMA.

View full profile
Richard Hobbs

Richard Hobbs

Professor and Head of Primary Care Health Services

Richard Hobbs is Professor and Head of Primary Care Health Sciences at the University of Oxford, UK. He is Co-Director of the Quality and Outcomes Review Panel and Deputy Director of the National Institute for Health Research National School for Primary Care Research.

Professor Hobbs serves on numerous scientific boards and is chair of the European Society of Cardiology (ESC) Council of Primary Care, as well as the Prevention and Care Board of the British Heart Foundation (BHF). His publications include 25 book chapters, nine edited books and more than 250 original papers in peer-reviewed journals.

View full profile
Katherine Tuttle

Katherine Tuttle

Executive Director of Research

Dr Katherine R Tuttle, is Professor of Medicine in the Nephrology Division and Kidney Research Institute at the University of Washington, US. Executive Director for Research at Providence Inland Northwest Health, and a Co-Principal Investigator for the ITHS. Her major research interests are in the areas of clinical and translational science and precision medicine for diabetic kidney disease, chronic kidney disease, diabetes, and hypertension. Dr Tuttle has led a major patient registry as well as clinical trials in these fields that have delivered breakthrough therapies to prevent kidney failure and cardiovascular events.

View full profile